Targeting nitric oxide in the gastrointestinal tract

Current Opinion in Investigational Drugs

Volumn 5, Issue 5, 2004, Pages 529-536

  Dijkstra, Gerard ^a   Van Goor, Harry ^a   Jansen, Peter Lm ^a   Moshage, Han ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

ENOS; Inflammation; INOS; Intestine; Motility; Nitric oxide; NNOS

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, HUMAN; NOS3 PROTEIN, HUMAN;

ANIMAL; BIOSYNTHESIS; ENZYMOLOGY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMAN; INFLAMMATION; INTESTINE MUCOSA; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VASCULARIZATION;

ANIMALS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III;

EID: 3342940875     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. Singer II, Kawka DW, Scott S, Weidner JR, Mumford RA, Riehl TE, Stenson WF: Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology (1996) 111(4):871-885.
2. Iwashita E, Miyahara T, Hino K, Tokunaga T, Wakisaka H, Sawazaki Y: High nitric oxide synthase activity in endothelial cells in ulcerative colitis. J Gastroenterol (1995) 30(4):551-554.
3. Miller MJ, Thompson JH, Zhang XJ, Sadowska-Krowicka H, Kakkis JL, Munshi UK, Sandoval M, Rossi JL, Eloby-Childress S, Beckman JS, Zu Y et al: Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis. Gastroenterology (1995) 109(5):1475-1483.
4. Millar TM, Stevens CR, Benjamin N, Eisenthal R, Harrison R, Blake DR: Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett (1998) 427(2):225-228.
5. Duncan C, Dougall H, Johnston P, Green S, Brogan R, Leifert C, Smith L, Golden M, Benjamin N: Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat Med (1995) 1(6):546-551.
6. McKnight GM, Smith LM, Drummond RS, Duncan CW, Golden M, Benjamin N: Chemical synthesis of nitric oxide in the stomach from dietary nitrate in humans. Gut (1997) 40(2):211-214.
7. Lundberg JO, Weitzberg E, Lundberg JM, Alving K: Intragastric nitric oxide production in humans: Measurements in expelled air. Gut (1994) 35(11):1543-1546.
8. Nagase S, Takemura K, Ueda A, Hirayama A, Aoyagi K, Kondoh M, Koyama A: A novel nonenzymatic pathway for the generation of nitric oxide by the reaction of hydrogen peroxide and D- or L-arginine. Biochem Biophys Res Commun (1997) 233(1):150-153.
9. Goretski J, Zafiriou OC, Hollocher TC: Steady-state nitric oxide concentrations during denitrification. J Biol Chem (1990) 265(20):11535-11538.
10. Brittain T, Blackmore R, Greenwood C, Thomson AJ: Bacterial nitrite-reducing enzymes. Eur J Biochem(1992) 209(3):793-802.
11. Bult H, Boeckxstaens GE, Pelckmans PA, Jordaens FH, Van Maercke YM, Herman AG: Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature (1990) 345(6273):346-347.
12. Mashimo H, Goyal RK: Lessons from genetically engineered animal models. IV. Nitric oxide synthase gene knockout mice. Am J Physiol Gastrointest Liver Physiol (1999) 277(4 Pt 1):G745-G750.
13. Mearin F, Mourelle M, Guarner F, Salas A, Riveros-Moreno V, Moncada S, Malagelada JR: Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest (1993) 23(11):724-728.
14. Vanderwinden JM, Mailleux P, Schiffmann SN, Vanderhaeghen JJ, De Laet MH: Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis. N Engl J Med (1992) 327(8):511-515.
15. Larsson LT, Shen Z, Ekblad E, Sundler F, Alm P, Andersson KE: Lack of neuronal nitric oxide synthase in nerve fibers of aganglionic intestine: A clue to Hirschsprung's disease. J Pediatr Gastroenterol Nutr (1995) 20(1):49-53.
16. Slivka A, Chuttani R, Carr-Locke DL, Kobzik L, Bredt DS, Loscalzo J, Stamler JS: Inhibition of sphincter of Oddi function by the nitric oxide carrier S-nitroso-N-acetylcysteine in rabbits and humans. J Clin Invest (1994) 94(5):1792-1798.
17. Schouten WR, Briel JW, Boerma MO, Auwerda JJ, Wilms EB, Graatsma BH: Pathophysiological aspects and clinical outcome of intra-anal application of isosorbide dinitrate in patients with chronic anal fissure. Gut (1996) 39(3):465-469.
18. Parker WA, MacKinnon GL: Nitrites in the treatment of diffuse esophageal spasm. Drug Intell Clin Pharm (1981) 15(10):806- 807.
19. Hirsch DP, Holloway RH, Tytgat GN, Boeckxstaens GE: Involvement of nitric oxide in human transient lower esophageal sphincter relaxations and esophageal primary peristalsis. Gastroenterology (1998) 115(6):1374-1380.
20. Stark ME, Szurszewski JH: Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology (1992) 103(6):1928-1949.
21. Russo A, Fraser R, Adachi K, Horowitz M, Boeckxstaens G: Evidence that nitric oxide mechanisms regulate small intestinal motility in humans. Gut (1999) 44(1):72-76.
22. Wink DA, Cook JA, Kim SY, Vodovotz Y, Pacelli R, Krishna MC, Russo A, Mitchell JB, Jourd'heuil D, Miles AM, Grisham MB: Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. Chemical aspects involved in the balance between oxidative and nitrosative stress. J Biol Chem(1997) 272(17):11147-11151.
23. Mourelle M, Casellas F, Guarner F, Salas A, Riveros-Moreno V, Moncada S, Malagelada JR: Induction of nitric oxide synthase in colonic smooth muscle from patients with toxic megacolon. Gastroenterology (1995) 109(5):1497-1502.
24. Brasitus TA, Field M, Kimberg DV: Intestinal mucosal cyclic GMP: Regulation and relation to ion transport. Am J Physiol (1976) 231(1):275-282.
25. Allescher HD, Kurjak M, Huber A, Trudrung P, Schusdziarra V: Regulation of VIP release from rat enteric nerve terminals: Evidence for a stimulatory effect of NO. Am J Physiol (1996) 271(4 Pt 1):G568-G574.
26. 2 in nitroprusside-stimulated rat colonic ion transport. Am J Physiol (1996) 270(3 Pt 1):C832-C840.
27. Tamai H, Gaginella TS: Direct evidence for nitric oxide stimulation of electrolyte secretion in the rat colon. Free Radic Res Commun (1993) 19(4):229-239.
28. Mascolo N, Izzo AA, Barbato F, Capasso F: Inhibitors of nitric oxide synthetase prevent castor-oil-induced diarrhoea in the rat. Br J Pharmacol (1993) 108(4):861-864.
29. Izzo AA, Gaginella TS, Mascolo N, Capasso F: Nitric oxide as a mediator of the laxative action of magnesium sulphate. Br J Pharmacol (1994) 113(1):228-232.
30. Izzo AA, Sautebin L, Rombola L, Capasso F: The role of constitutive and inducible nitric oxide synthase in senna- and cascara-induced diarrhoea in the rat. Eur J Pharmacol (1997) 323(1):93-97.
31. Gaginella TS, Mascolo N, Izzo AA, Autore G, Capasso F: Nitric oxide as a mediator of bisacodyl and phenolphthalein laxative action: Induction of nitric oxide synthase. J Pharmacol Exp Ther (1994) 270(3):1239-1245.
32. Casellas F, Mourelle M, Papo M, Guarner F, Antolin M, Armengol JR, Malagelada JR: Bile acid induced colonic irritation stimulates intracolonic nitric oxide release in humans. Gut (1996) 38(5):719-723.
33. Lundberg JO, Herulf M, Olesen M, Bohr J, Tysk C, Wiklund NP, Morcos E, Hellstrom PM, Weitzberg E, Jarnerot G: Increased nitric oxide production in collagenous and lymphocytic colitis. Eur J Clin Invest (1997) 27(10):869-871.
34. Perner A, Andresen L, Normark M, Fischer-Hansen B, Sorensen S, Eugen-Olsen J, Rask-Madsen J: Expression of nitric oxide synthases and effects of L-arginine and L-NMMA on nitric oxide production and fluid transport in collagenous colitis. Gut (2001) 49(3):387-394.
35. Qiu B, Pothoulakis C, Castagliuolo I, Nikulasson Z, LaMont JT: Nitric oxide inhibits rat intestinal secretion by Clostridium difficile toxin A but not Vibrio cholerae enterotoxin. Gastroenterology (1996) 111(2):409-418.
36. Beubler E, Schirgi-Degen A: Nitric oxide counteracts 5-hydroxytryptamine- and cholera toxin-induced fluid secretion and enhances the effect of oral rehydration solution. Eur J Pharmacol (1997) 326(2-3):223-228.
37. Izzo AA, Mascolo N, Capasso F: Nitric oxide as a modulator of intestinal water and electrolyte transport. Dig Dis Sci (1998) 43(8):1605-1620.
38. + channel modulation in the proabsorptive effect of nitric oxide in the rat jejunum in vivo. Eur J Pharmacol (1996) 316(2-3):257-262.
39. Lippe IT, Holzer P: Participation of endothelium-derived nitric oxide but not prostacyclin in the gastric mucosal hyperaemia due to acid back-diffusion. Br J Pharmacol (1992) 105(3):708-714.
40. MacNaughton WK, Cirino G, Wallace JL: Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach. Life Sci (1989) 45(20):1869-1876.
41. Masuda E, Kawano S, Nagano K, Tsuji S, Takei Y, Tsujii M, Oshita M, Michida T, Kobayashi I, Nakama A: Endogenous nitric oxide modulates ethanol-induced gastric mucosal injury in rats. Gastroenterology (1995) 108(1):58-64.
42. Kitagawa H, Takeda F, Kohei H: Effect of endothelium-derived relaxing factor on the gastric lesion induced by HCl in rats. J Pharmacol Exp Ther (1990) 253(3):1133-1137.
43. Lopez-Belmonte J, Whittle BJ, Moncada S: The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. Br J Pharmacol (1993) 108(1):73-78.
44. Elliott SN, McKnight W, Cirino G, Wallace JL: A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology (1995) 109(2):524-530.
45. Wallace JL, Cirino G, McKnight GW, Elliott SN: Reduction of gastrointestinal injury in acute endotoxic shock by flurbiprofen nitroxybutylester. Eur J Pharmacol (1995) 280(1):63-68.
46. Wallace JL, McKnight W, Wilson TL, Del Soldato P, Cirino G: Reduction of shock-induced gastric damage by a nitric oxide-releasing aspirin derivative: Role of neutrophils. Am J Physiol Gastrointest Liver Physiol (1997) 273(6 Pt 1):G1246-G1251.
47. Takeuchi K, Mizoguchi H, Araki H, Komoike Y, Suzuki K: Lack of gastric toxicity of nitric oxide-releasing indomethacin, NCX- 530, in experimental animals. Dig Dis Sci (2001) 46(8):1805-1818.
48. Wallace JL, Reuter B, Cicala C, McKnight W, Grisham MB, Cirino G: Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology (1994) 107(1):173-179.
49. Kubes P, Kanwar S, Niu XF, Gaboury JP: Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J (1993) 7(13):1293-1299.
50. Fiorucci S, Santucci L, Antonelli E, Distrutti E, Del Sero G, Morelli O, Romani L, Federici B, Del Soldato P, Morelli A: NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Gastroenterology (2000) 118(2):404-421.
51. Brown JF, Keates AC, Hanson PJ, Whittle BJ: Nitric oxide generators and cGMP stimulate mucus secretion by rat gastric mucosal cells. Am J Physiol (1993) 265(3 Pt 1):G418-G422.
52. Konturek SJ, Brzozowski T, Majka J, Pytko-Polonczyk J, Stachura J: Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers. Eur J Pharmacol (1993) 239(1-3):215-217.
53. McCafferty DM, Mudgett JS, Swain MG, Kubes P: Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology (1997) 112(3):1022-1027.
54. Schaffer MR, Efron PA, Thornton FJ, Klingel K, Gross SS, Barbul A: Nitric oxide, an autocrine regulator of wound fibroblast synthetic function. J Immunol (1997) 158(5):2375-2381.
55. Thornton FJ, Schaffer MR, Witte MB, Moldawer LL, MacKay SL, Abouhamze A, Tannahill CL, Barbul A: Enhanced collagen accumulation following direct transfection of the inducible nitric oxide synthase gene in cutaneous wounds. Biochem Biophys Res Commun (1998) 246(3):654-659.
56. Kubes P: Nitric oxide modulates epithelial permeability in the feline small intestine. Am J Physiol (1992) 262(6 Pt 1):G1138-G1142.
57. Menconi MJ, Unno N, Smith M, Aguirre DE, Fink MP: Nitric oxide donor-induced hyperpermeability of cultured intestinal epithelial monolayers: Role of superoxide radical, hydroxyl radical, and peroxynitrite. Biochim Biophys Acta (1998) 1425(1):189-203.
58. Xie QW, Kashiwabara Y, Nathan C: Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem (1994) 269(7):4705-4708.
59. Jobin C, Sartor RB: The I kappa B/NF-κB system: A key determinant of mucosal inflammation and protection. Am J Physiol Cell Physiol (2000) 278(3):C451-C462.
60. Jobin C, Haskill S, Mayer L, Panja A, Sartor RB: Evidence for altered regulation of IκBα degradation in human colonic epithelial cells. J Immunol (1997) 158(1):226-234.
61. Moochhala S, Chhatwal VJ, Chan ST, Ngoi SS, Chia YW, Rauff A: Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis (1996) 17(5):1171-1174.
62. Godkin AJ, De Belder AJ, Villa L, Wong A, Beesley JE, Kane SP, Martin JF: Expression of nitric oxide synthase in ulcerative colitis. Eur J Clin Invest (1996) 26(10):867-872.
63. Dijkstra G, Moshage H, van Dullemen HM, de Jager-Krikken A, Tiebosch AT, Kleibeuker JH, Jansen PL, van Goor H: Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol (1998) 186(4):416-421.
64. Kimura H, Hokari R, Miura S, Shigematsu T, Hirokawa M, Akiba Y, Kurose I, Higuchi H, Fujimori H, Tsuzuki Y, Serizawa H, Ishii H: Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut (1998) 42(2):180-187.
65. Roberts PJ, Riley GP, Morgan K, Miller R, Hunter JO, Middleton SJ: The physiological expression of inducible nitric oxide synthase (iNOS) in the human colon. J Clin Pathol (2001) 54(4):293-297.
66. Perner A, Andresen L, Normark M, Rask-Madsen J: Constitutive expression of inducible nitric oxide synthase in the normal human colonic epithelium. Scand J Gastroenterol (2002) 37(8):944-948.
67. Naumann M: Nuclear factor-κB activation and innate immune response in microbial pathogen infection. Biochem Pharmacol (2000) 60(8):1109-1114.
68. Witthoft T, Eckmann L, Kim JM, Kagnoff MF: Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells. Am J Physiol Gastrointest Liver Physiol (1998) 275(3 Pt 1):G564-G571.
69. Fang FC: Perspectives series: Host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest (1997) 99(12):2818-2825.
70. ter Steege J, Buurman W, Arends JW, Forget P: Presence of inducible nitric oxide synthase, nitrotyrosine, CD68, and CD14 in the small intestine in celiac disease. Lab Invest (1997) 77(1):29-36.
71. Johnston JD, Harvey CJ, Menzies IS, Treacher DF: Gastrointestinal permeability and absorptive capacity in sepsis. Crit Care Med(1996) 24(7):1144-1149.
72. Unno N, Wang H, Menconi MJ, Tytgat SH, Larkin V, Smith M, Morin MJ, Chavez A, Hodin RA, Fink MP: Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology (1997) 113(4):1246-1257.
73. Sorrells DL, Friend C, Koltuksuz U, Courcoulas A, Boyle P, Garrett M, Watkins S, Rowe MI, Ford HR: Inhibition of nitric oxide with aminoguanidine reduces bacterial translocation after endotoxin challenge in vivo. Arch Surg (1996) 131(11):1155-1163.
74. McCafferty DM: Peroxynitrite and inflammatory bowel disease. Gut (2000) 46(3):436-439.
75. Hogaboam CM, Jacobson K, Collins SM, Blennerhassett MG: The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am J Physiol (1995) 268(4 Pt 1):G673-G684.
76. Rachmilewitz D, Karmeli F, Okon E, Bursztyn M: Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut (1995) 37(2):247-255.
77. Ribbons KA, Currie MG, Connor JR, Manning PT, Allen PC, Didier P, Ratterree MS, Clark DA, Miller MJS: The effect of inhibitors of inducible nitric oxide synthase on chronic colitis in the rhesus monkey. J Pharmacol Exp Ther (1997) 280(2):1008-1015.
78. Conner EM, Chen Y, Gronberg A: Effect of nitric oxide synthase (NOS) inhibition on dextran sulfate sodium (DSS)-induced colitis in rats and mice. Gastroenterology (1995) 108:A801.
79. Pfeiffer CJ, Qiu BS: Effects of chronic nitric oxide synthase inhibition on TNB-induced colitis in rats. J Pharm Pharmacol (1995) 47(10):827-832.
80. Zingarelli B, Szabo C, Salzman AL: Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase. Gut (1999) 45(2):199-209.
81. McCafferty DM, Miampamba M, Sihota E, Sharkey KA, Kubes P: Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice. Gut (1999) 45(6):864-873.
82. Qiu BS, Mashimo H, Vallance BA, Blennerhassett PA, Collins SM: Susceptibility of mice with specific NOS gene deletions to experimental colitis. Gastroenterology (1998) 114:A1065.
83. Hokari R, Kato S, Matsuzaki K, Kuroki M, Iwai A, Kawaguchi A, Nagao S, Miyahara T, Itoh K, Sekizuka E, Nagata H et al: Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis. Free Radic Biol Med (2001) 31(2):153-163.
84. Krieglstein CF, Cerwinka WH, Laroux FS, Salter JW, Russell JM, Schuermann G, Grisham MB, Ross CR, Granger DN: Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: Divergent roles of superoxide and nitric oxide. J Exp Med (2001) 194(9):1207- 1218.
85. Beck PL, Xavier R, Wong J, Ezedi I, Mashimo H, Mizoguchi A, Mizoguchi E, Bhan AK, Podolsky DK: Paradoxical roles of different nitric oxide synthase isoforms in colonic injury. Am J Physiol Gastrointest Liver Physiol (2004) 286(1):G137-G147.
86. McCafferty DM, Sihota E, Muscara M, Wallace JL, Sharkey KA, Kubes P: Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice. Am J Physiol Gastrointest Liver Physiol (2000) 279(1):G90-G99.
87. Lundberg JO, Herulf M, Olesen M, Bohr J, Tysk C, Wiklund NP, Morcos E, Hellstrom PM, Weitzberg E, Jarnerot G: Increased nitric oxide production in collagenous and lymphocytic colitis. Eur J Clin Invest (1997) 27(10):869-871.
88. Wallace JL, Vergnolle N, Muscara MN, Asfaha S, Chapman K, McKnight W, Del Soldato P, Morelli A, Fiorucci S: Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. Gastroenterology (1999) 117(3):557-566.
89. Fiorucci S, Antonelli E, Santucci L, Morelli O, Miglietti M, Federici B, Mannucci R, Del Soldato P, Morelli A: Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats. Gastroenterology (1999) 116(5):1089-1106.
90. Matthews JR, Botting CH, Panico M, Morris HR, Hay RT: Inhibition of NF-κB DNA binding by nitric oxide. Nucleic Acids Res (1996) 24(12):2236-2242.
91. Wallace JL, Del Soldato P: The therapeutic potential of NO-NSAIDs. Fundam Clin Pharmacol (2003) 17(1):11-20.
92. Baraldi PG, Romagnoli R, Del Carmen Nunez M, Perretti M, Paul-Clark MJ, Ferrario M, Govoni M, Benedini F, Ongini E: Synthesis of nitro esters of prednisolone, new compounds combining pharmacological properties of both glucocorticoids and nitric oxide. J Med Chem (2004) 47(3):711-719.
93. Naimi E, Zhou A, Khalili P, Wiebe LI, Balzarini J, De Clercq E, Knaus EE: Synthesis of 3′- and 5′-nitrooxy pyrimidine nucleoside nitrate esters: "Nitric oxide donor" agents for evaluation as anticancer and antiviral agents. J Med Chem (2003) 46(6):995-1004.
94. Lavagna C, Del Soldato P, Burgaud JL, Rampal P: Nitric oxide-releasing non steroidal anti-inflammatory drugs: A new generation of anti-tumoral molecules. Curr Cancer Drug Targets (2003) 3(6):407-426.
95. Rao CV, Kawamori T, Hamid R, Reddy BS: Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis (1999) 20(4):641-644.
96. Moharram S, Zhou A, Wiebe LI, Knaus EE: Design and synthesis of 3′- and 5′-O-(3-benzenesulfonylfuroxan-4-yl)- 2′-deoxyuridines: Biological evaluation as hybrid nitric oxide donor-nucleoside anticancer agents. J Med Chem (2004) 47(7):1840-1846.